Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Liver Neoplasms 1Diarrhea 1Carcinoma, Hepatocellular 1

Interventions

Octreotide 6Irinotecan 6Loperamide 5Probiotics 3Leucovorin 3Fluorouracil 3Fecal Microbiota Transplantation 3Calcium Aluminosilicate 3maltodextrin 2telotristat ethyl 1shosaiko-to 1lanreotide 1isatuximab 1ceterizine hydrochloride 1capivasertib 1cabazitaxel 1bile acid binding proteins 1XRP6258 1Theophylline 1Temozolomide 1Surveys and Questionnaires 1Sulfasalazine 1Sugars 1Standard of Care 1Raloxifene Hydrochloride 1Radiation 1Prednisone 1PHY 906 1Oxaliplatin 1Long-Term Synaptic Depression 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Diarrhea × shosaiko-to × Clear all
NCT04926545 2024-07-30

XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

Guangzhou University of Traditional Chinese Medicine

Phase NA Completed
24 enrolled

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡